Corbin Crushes Cancer
Donation protected
As many of you know, Corbin was diagnosed with progressed neuroblastoma just a few short months ago in April 2019. This new diagnosis came after he was declared cancer-free in November 2018 from his initial cancer diagnosis in October 2018, in which a malignant tumor was successfully removed with surgery alone. We were told there was only a 5% chance the cancer would return, yet it did just that. This news was beyond devastating for all of us; however, instead of beating us down, it has highlighted the strength and resiliency within our family! It lit a fire that burns with a fierce flame...WE WILL BEAT THIS!!! Since May 2019, Corbin has endured five cycles of chemotherapy. We are currently awaiting test results to find out how well the chemotherapy has worked; however, regardless of how well the chemotherapy has worked, our battle is far from over.
Corbin must move into the next phase of treatment, immunotherapy (antibody therapy), to 'mop up' any remaining cancer cells in his body. We have chosen to proceed with immunotherapy at Memorial Sloan Kettering Cancer Center in New York City, the #1 cancer treatment institution for neuroblastoma in the entire WORLD! Their goal is to cure children of neuroblastoma without destroying their bodies in the process. Their innovative treatment approaches that limit overall toxicity of treatment, their reputation as the WORLD LEADERS in treating and curing neuroblastoma, and their individualized approach to treatment is why we will fly to New York every month for as long as it takes! We will do ANYTHING and EVERYTHING to cure Corbin!!
Corbin's first antibody treatment is scheduled to begin September 16, 2019...just a few short weeks away! We will spend around ten days a month in New York City as he undergoes each treatment cycle. Currently, the plan for Corbin is to receive five cycles of antibody treatment and then to proceed to vaccine therapy.
As a two income family that has essentially become a one income family since Corbin started treatment, we need your help to get through these next phases of Corbin's road to a cure! All funds raised will help our family with: expenses related to traveling for treatment, unexpected costs related to treatment, and household expenses over the next several months.
We are very excited and feel so grateful Corbin has access to the VERY BEST TREATMENT IN THE WORLD! We sincerely thank you all who support us through donations, sharing this fundraiser, and prayers.
Please follow Corbin's road to a cure on Facebook: Corbin Beats Cancer
Below you will find information about the treatments Corbin will begin next month straight from the MSKCC website :
Antibody-Based Therapies
Standard treatment for neuroblastoma has typically involved intensive chemotherapy, often combined with stem cell transplantation, which can lead to severe side effects and a limited chance of a cure. For more than 20 years, Memorial Sloan Kettering investigators have used an antibody – a type of immune system protein – called 3F8 to treat neuroblastoma. 3F8 in combination with surgery and chemotherapy has significantly improved the cure rates for children with high-risk neuroblastoma, while reducing the intensity of chemotherapy required.
Every day, our specialized team of physicians, nurse practitioners, nurses, social workers, and child life specialists routinely treats children with 3F8 in an outpatient setting. We have recently developed an enhanced version of 3F8 that is a near likeness of a human antibody. It promises to provide more specific, powerful treatment for neuroblastoma. Also, because of its makeup, it is a treatment that can be given for longer periods of time than other antibodies.
In addition, our investigators are studying how to use other antibody-based therapies to harness the power of a patient’s own immune system to fight neuroblastoma. And in children and young adults with bone sarcomas, we are conducting trials of newly developed antibodies that will direct immune system cells to attack these tumors.
Vaccines and Immunity-Modulating Therapies
Memorial Sloan Kettering researchers are also investigating other therapies that target the immune system. We are conducting clinical trials of ipilimumab, an antibody against a molecule found on the surface of some lymphocytes. Masking this molecule with the antibody can free the immune system to attack tumor cells more intensely.
A powerful vaccine directed at tumor cells has shown encouraging results in patients with high-risk metastatic neuroblastoma. In the past, it was nearly impossible to keep patients with relapsed neuroblastoma in a second remission. With the introduction of these vaccines, most patients are alive and well.
Corbin must move into the next phase of treatment, immunotherapy (antibody therapy), to 'mop up' any remaining cancer cells in his body. We have chosen to proceed with immunotherapy at Memorial Sloan Kettering Cancer Center in New York City, the #1 cancer treatment institution for neuroblastoma in the entire WORLD! Their goal is to cure children of neuroblastoma without destroying their bodies in the process. Their innovative treatment approaches that limit overall toxicity of treatment, their reputation as the WORLD LEADERS in treating and curing neuroblastoma, and their individualized approach to treatment is why we will fly to New York every month for as long as it takes! We will do ANYTHING and EVERYTHING to cure Corbin!!
Corbin's first antibody treatment is scheduled to begin September 16, 2019...just a few short weeks away! We will spend around ten days a month in New York City as he undergoes each treatment cycle. Currently, the plan for Corbin is to receive five cycles of antibody treatment and then to proceed to vaccine therapy.
As a two income family that has essentially become a one income family since Corbin started treatment, we need your help to get through these next phases of Corbin's road to a cure! All funds raised will help our family with: expenses related to traveling for treatment, unexpected costs related to treatment, and household expenses over the next several months.
We are very excited and feel so grateful Corbin has access to the VERY BEST TREATMENT IN THE WORLD! We sincerely thank you all who support us through donations, sharing this fundraiser, and prayers.
Please follow Corbin's road to a cure on Facebook: Corbin Beats Cancer
Below you will find information about the treatments Corbin will begin next month straight from the MSKCC website :
Antibody-Based Therapies
Standard treatment for neuroblastoma has typically involved intensive chemotherapy, often combined with stem cell transplantation, which can lead to severe side effects and a limited chance of a cure. For more than 20 years, Memorial Sloan Kettering investigators have used an antibody – a type of immune system protein – called 3F8 to treat neuroblastoma. 3F8 in combination with surgery and chemotherapy has significantly improved the cure rates for children with high-risk neuroblastoma, while reducing the intensity of chemotherapy required.
Every day, our specialized team of physicians, nurse practitioners, nurses, social workers, and child life specialists routinely treats children with 3F8 in an outpatient setting. We have recently developed an enhanced version of 3F8 that is a near likeness of a human antibody. It promises to provide more specific, powerful treatment for neuroblastoma. Also, because of its makeup, it is a treatment that can be given for longer periods of time than other antibodies.
In addition, our investigators are studying how to use other antibody-based therapies to harness the power of a patient’s own immune system to fight neuroblastoma. And in children and young adults with bone sarcomas, we are conducting trials of newly developed antibodies that will direct immune system cells to attack these tumors.
Vaccines and Immunity-Modulating Therapies
Memorial Sloan Kettering researchers are also investigating other therapies that target the immune system. We are conducting clinical trials of ipilimumab, an antibody against a molecule found on the surface of some lymphocytes. Masking this molecule with the antibody can free the immune system to attack tumor cells more intensely.
A powerful vaccine directed at tumor cells has shown encouraging results in patients with high-risk metastatic neuroblastoma. In the past, it was nearly impossible to keep patients with relapsed neuroblastoma in a second remission. With the introduction of these vaccines, most patients are alive and well.
Organizer
Angela Bain Stillman
Organizer
Bedford, TX